Topotecan in Treating Patients With Myelodysplastic Syndrome
Leukemia
-
-
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
-
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
-
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
-
Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
-
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
-
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
-
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
-
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes